Patients can present with a multitude of non-specific symptoms, including weight loss and jaundice with and without abdominal pain. At the time of presentation, only 10-20% of patients will be diagnosed with a stage that is amenable to surgical resection and potential cure.
Up to 10% to 15% of pancreatic cancers are associated with an underlying genetic etiology. There is still is some debate as to the exact patient population to screen and which screening test(s) are the most accurate and cost-effective. Read more . . .